Armata Pharmaceuticals (ARMP) Receivables - Net (2013 - 2026)

Armata Pharmaceuticals (ARMP) reported Receivables - Net of $100000.0 for Q1 2026, down 50.0% on a YoY basis from $200000.0 in Q1 2025, and down 80.0% sequentially from $500000.0 in Q4 2025.

Armata Pharmaceuticals (ARMP) Receivables - Net (2013 - 2026) Analysis & Trends

Armata Pharmaceuticals (ARMP) has 9 years of Receivables - Net data on file, last reported at $100000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Receivables - Net fell 50.0% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $100000.0 (down 50.0% YoY), and the FY2025 full-year result was $500000.0, down 28.57% from the prior year.
  • Receivables - Net slipped to $100000.0 in Q1 2026, from $500000.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $2.2 million in Q2 2025 to a low of $100000.0 in Q1 2026.
  • A 4-year average of $912500.0 and a median of $600000.0 in 2024 frame the typical range for Receivables - Net.
  • Across the five-year window, Receivables - Net sank 53.33% in 2024 and surged 340.0% in 2025, its largest moves.
  • Tracing ARMP's Receivables - Net over 4 years: stood at $1.5 million in 2023, then slumped by 53.33% to $700000.0 in 2024, then dropped by 28.57% to $500000.0 in 2025, then plunged by 80.0% to $100000.0 in 2026.
  • Business Quant data shows ARMP's Receivables - Net at $100000.0 in Q1 2026, $500000.0 in Q4 2025, and $2.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Armata Pharmaceuticals 191.29 Mn 186.49 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 500,000.00
Dec 31, 2025 500,000.00
Jun 30, 2025 2.20 Mn
Jun 30, 2025 2.20 Mn
Mar 31, 2025 200,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 700,000.00
Dec 31, 2024 700,000.00
Sep 30, 2024 1.60 Mn
Sep 30, 2024 1.60 Mn
Jun 30, 2024 500,000.00
Jun 30, 2024 500,000.00
Dec 31, 2023 1.50 Mn
Dec 31, 2023 1.50 Mn
Mar 31, 2017 15,000.00
Mar 31, 2017 15,000.00
Dec 31, 2016 12,000.00
Dec 31, 2016 12,000.00